MARGARET NELSON: Open Payments
NPI 1326751678 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 58 payments from 9 companies in 2025. Trend: 2023 $295 · 2024 $822 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $312 |
| AstraZeneca Pharmaceuticals LP | 10 | $224 |
| GENZYME CORPORATION | 8 | $180 |
| Viatris Specialty LLC | 9 | $163 |
| Mallinckrodt Hospital Products Inc. | 5 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| Amgen Inc. | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| United Therapeutics Corporation | 1 | $25 |
Products named: DUPIXENT, NUCALA, YUPELRI, TRELEGY ELLIPTA, FASENRA, ACTHAR, TEZSPIRE, JASCAYD.
Industry payments across MS — which companies pay providers there.
